Allo-APZ2-EB for treating dystrophic and junctional epidermolysis bullosa in people of any age [ID6746] Technology appraisal guidance Alpelisib for treating severe PIK3CA-related overgrowth spectrum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results